Literature DB >> 22155594

Bioactive polar compounds from stem bark of Magnolia officinalis.

Sheng-xian Yu1, Ren-yi Yan, Ri-xin Liang, Wei Wang, Bin Yang.   

Abstract

Two new phenylethanoid glycosides magnoloside D (1) and E (2), together with nine known compounds, were isolated from the polar part of methanol extract of the stem bark of Magnolia officinalis. The structures of the new compounds were established on the basis of spectral analysis. Anti-spasmodic activity of four major constituents (3, 4, 9 and 11) was tested in isolated colon of rat, compounds 3, 4, and 9 showed inhibition against acetylcholine, with the effect similar to that of magnolol and honokiol. At the same time, antioxidant activity of the isolated compounds was investigated using a DPPH and an ORAC assay. All of the compounds, except compound 8 showed potent antioxidant capacity in the ORAC assay, while compounds 1-5 and 11 exhibited potent antioxidant activity in the DPPH assay.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155594     DOI: 10.1016/j.fitote.2011.11.020

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

Review 1.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

2.  Application of Multiple-Source Data Fusion for the Discrimination of Two Botanical Origins of Magnolia Officinalis Cortex Based on E-Nose Measurements, E-Tongue Measurements, and Chemical Analysis.

Authors:  Wenguang Jing; Xiaoliang Zhao; Minghua Li; Xiaowen Hu; Xianlong Cheng; Shuangcheng Ma; Feng Wei
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

3.  In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Guo-Ying Zuo; Xin-Juan Zhang; Jun Han; Yu-Qing Li; Gen-Chun Wang
Journal:  BMC Complement Altern Med       Date:  2015-12-01       Impact factor: 3.659

4.  Magnolia extract (BL153) ameliorates kidney damage in a high fat diet-induced obesity mouse model.

Authors:  Wenpeng Cui; Yangwei Wang; Qiang Chen; Weixia Sun; Lu Cai; Yi Tan; Ki-Soo Kim; Ki Ho Kim; Young Heui Kim
Journal:  Oxid Med Cell Longev       Date:  2013-11-28       Impact factor: 6.543

5.  Nine phenylethanoid glycosides from Magnolia officinalis var. biloba fruits and their protective effects against free radical-induced oxidative damage.

Authors:  Lanlan Ge; Wenhui Zhang; Gao Zhou; Bingxin Ma; Qigui Mo; Yuxin Chen; Youwei Wang
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

6.  Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases.

Authors:  Miaoqing Zhao; Yangyang Chen; Chao Wang; Wei Xiao; Shusheng Chen; Shuwei Zhang; Ling Yang; Yan Li
Journal:  Front Pharmacol       Date:  2019-01-11       Impact factor: 5.810

7.  Variation in the microbial community contributes to the improvement of the main active compounds of Magnolia officinalis Rehd. et Wils in the process of sweating.

Authors:  Qinahua Wu; Dan Wei; Linlin Dong; Yuping Liu; Chaoxiang Ren; Qianqian Liu; Cuiping Chen; Jiang Chen; Jin Pei
Journal:  Chin Med       Date:  2019-10-22       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.